Abstract
Introduction Sarcoidosis is an inflammatory disease of unknown etiology that affects multiple organs in the body. In most cases, the affected organ is the lung. Sarcoidosis risk factors include environmental exposures, genetic predisposition, and immunological factors. The main objective of this review was to assess whether exposure to respirable particles is associated with increased risk of sarcoidosis.
Methods A comprehensive search was conducted in scientific databases. Additional search of grey literature as well as handsearching of relevant records was performed. The search was restricted to studies published between January 1998 to October 2019. Meta-analysis was performed for studies that provided quantitative data.
Results After applying inclusion/exclusion criteria, nine articles were included in the systematic review and four in the meta-analysis. Quantitative analysis suggested that people exposed to respirable particles were approximately three times more likely to develop sarcoidosis compared to people who are unexposed.
Discussion and conclusion This study collected and aggregated available evidence that assessed exposure to respirable particles and risk of developing sarcoidosis. Evidence of increased association between exposure to respirable particles and sarcoidosis was strongly suggested based on our qualitative review. More rigorous epidemiologic exposure studies are needed to generate data that would accurately determine the risk and causal pathways through which exposure to respirable particles could lead to the development of sarcoidosis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
